This topic contains a solution. Click here to go to the answer

Author Question: Bacterial protein synthesis inhibitors have selective toxicity because: 1. susceptible strains of ... (Read 78 times)

melina_rosy

  • Hero Member
  • *****
  • Posts: 531
Bacterial protein synthesis inhibitors have selective toxicity because:
 
  1. susceptible strains of bacteria are affected.
  2. biochemical processes are the same.
  3. human ribosomes are larger and denser than bacterial ribosomes.
  4. antibacterial activity is broad-spectrum.

Question 2

The emergency department nurse anticipates that which clients may be treated with ertapenem (Invanz)?
 
  Standard Text: Select all that apply.
  1. College student diagnosed with community-acquired pneumonia
  2. Client diagnosed with complicated urinary tract infection (UTI)
  3. Diabetic client with an infected toe
  4. Young child diagnosed with H. influenzae otitis media
  5. Older client diagnosed with community-acquired methicillin-resistant S. aureus (MRSA)



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

emily12345

  • Sr. Member
  • ****
  • Posts: 321
Answer to Question 1

Correct Answer: 3
Rationale 1: Susceptible strains of bacteria are targeted by the drug's antibacterial activity.
Rationale 2: Biochemical processes that are the same would be targeted by the drug.
Rationale 3: Human ribosomes are larger and denser than bacterial ribosomes. As a result, human ribosomes are not targeted by the drug's antibacterial activity.
Rationale 4: The spectrum of an antibacterial drug describes the range of bacteria it is effective against.
Global Rationale: Human ribosomes are larger and denser than bacterial ribosomes. As a result, human ribosomes are not targeted by the drug's antibacterial activity. Susceptible strains of bacteria are targeted by the drug's antibacterial activity. Biochemical processes that are the same would be targeted by the drug. The spectrum of an antibacterial drug describes the range of bacteria it is effective against.

Answer to Question 2

Correct Answer: 1,2,3
Rationale 1: Ertapenem (Invanz) is approved for the treatment of community-acquired pneumonia.
Rationale 2: Ertapenem (Invanz) is approved for the treatment of complicated UTI.
Rationale 3: Ertapenem (Invanz) is approved for the treatment of diabetic foot infection.
Rationale 4: Ertapenem (Invanz) is not approved for the treatment of H. influenzae otitis media.
Rationale 5: Ertapenem (Invanz) is not approved for the treatment of MRSA.
Global Rationale: Invanz is approved for the treatment of serious abdominopelvic and skin infections, community-acquired pneumonia, complicated UTIs, and diabetic foot infections without concomitant osteomyelitis.




melina_rosy

  • Member
  • Posts: 531
Reply 2 on: Jul 23, 2018
Gracias!


jackie

  • Member
  • Posts: 324
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Recent studies have shown that the number of medication errors increases in relation to the number of orders that are verified per pharmacist, per work shift.

Did you know?

The human body's pharmacokinetics are quite varied. Our hair holds onto drugs longer than our urine, blood, or saliva. For example, alcohol can be detected in the hair for up to 90 days after it was consumed. The same is true for marijuana, cocaine, ecstasy, heroin, methamphetamine, and nicotine.

Did you know?

As many as 28% of hospitalized patients requiring mechanical ventilators to help them breathe (for more than 48 hours) will develop ventilator-associated pneumonia. Current therapy involves intravenous antibiotics, but new antibiotics that can be inhaled (and more directly treat the infection) are being developed.

Did you know?

Approximately one in four people diagnosed with diabetes will develop foot problems. Of these, about one-third will require lower extremity amputation.

Did you know?

Asthma cases in Americans are about 75% higher today than they were in 1980.

For a complete list of videos, visit our video library